Pretty quite past few days on the board. I just took a road
Pretty quite past few days on the board. I just took a road trip to the Redwood forest in Northern California… if you haven’t seen the tallest trees in the world and just see how enormous they really are… you need to go. It’s a beautiful thing to see. I am not a tree hugger either but some things in life are just worth seeing in person. Made my car look small when parked next to a huge Redwood.
I see there is no breaking news yet and just hasn’t happened. What news is coming first is the big question we all have. I am still betting that Nash news will be our first news. Now will that Nash news be accompanied by another big news of a Nash Partner? We can only hope… could we just as easily be pursuing a partner for mTNBC?
I think so…
Will a quick arbitration take place? I don’t believe it will be quick. It will start with offers from both sides before an arbitrator will actually be involved. The independent CRO audit being complete was the prerequisite for arbitration to even start. So that news is possible but closely held to the chest cards to play in this arbitration. I wouldn’t be surprised if Amarex makes a confidentiality clause of settlement of issues not to be released publicly. Money paid to Cytodyn will have to be reported on a 8K but not why. So don’t get our hopes up that we will hear everything we have been waiting for.
The next few weeks we should know if this audit allowed us to complete our BLA for HIV and clear up any safety issues so we can actually file the BLA. What was it that Dr Kelly said? 8-12 weeks and that was a couple of weeks ago. Is this our timeline for news? It might just be. Hopefully we hear something sooner but aside from Nash results or a partnership… we wait yet again.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
MOBILion Joins Waters' Fold: A New Era for Proteomics Ah, the biotech world just saw another big whirl with Waters Corporation snagging MOBILion Systems. Now, this isn't just some stroll in the market park. We're talking about weaving MOBILion's fancy high-resolution ion mobility separation tech right into Waters' already robust mass spectrometry setup. These folks are...
Continue Reading
Call me old-fashioned, but when cancer whispers in the shadows even after it's supposedly signed off the death certificate, you're dealing with one heck of a slippery adversary. That's where Montefiore Einstein Comprehensive Cancer Center comes in, armed with ten million greenbacks from the National Cancer Institute, primed to rattle the labyrinth of breast cancer...
Continue Reading
Diving Deep into JLL's Latest Acquisition If you blinked, you might have missed JLL Income Property Trust's latest power move. These folks just laid down $36 million for a prime 54,000-square-foot Class A distribution hub in Northborough, Massachusetts. This isn't just any run-of-the-mill facility; it's 100% leased to a heavy-hitting tenant for the next 14 years with neat...
Continue Reading
Sunrate Joins Forces with Netstorming When two industry powerhouses shake hands, it's wise to sit up and listen. Sunrate, the global whiz in payment solutions, has linked arms with Netstorming, a tech-savvy pioneer in the travel sector. This ironclad partnership was announced at World Travel Market London 2026. Owners of travel businesses should take note: things are...
Continue Reading
Shifting the GERD Treatment Paradigm While everyone's talking about breakthrough technologies like AI and blockchain in medicine, MemorialCare seems to have quietly flipped the script on treating gastroesophageal reflux disease (GERD). They're sidestepping conventional maneuvers by embracing two procedures known as transoral incisionless fundoplication (TIF) and its...
Continue Reading
Taking a Stroll Down Cherry Creek The move by Mill Creek Residential into Cherry Creek North is a bold one, but they aren't exactly newcomers to this high-end neighborhood. They're planting their flag with the Modera Second Avenue, targeting Denver's upscale renters. With a Walk Score of 89, the location is a sweet spot for deep-pocketed folks who want the boutiques and...
Continue Reading
Midterms Mingle with Financial Markets Folks, throw those ballots into the ring, because today the midterms are kicking things off and boy, are they shaking up the game on these prediction markets. Traders and exchanges are on their toes, and the money's flowing like cold brew in July. Robinhood, Intercontinental Exchange, CME Group, and others reported noticeable ripples...
Continue Reading
Recognizing a Game-Changer in Financial Wellness Vanessa Hering's name isn't just getting thrown around for no reason, folks. She's the client success officer at Beyond Finance, a heavyweight in the financial wellness arena, and she's just snagged the 2026 Herizon Award. This ain't some run-of-the-mill accolade; it acknowledges the profound changes she's spearheaded in...
Continue Reading
A New Legend in the Making Who would've thought we'd see the day when an SRT badge graced a Jeep Wrangler with such audacity? This ain't your typical Wrangler—they’ve slapped a bit of that CJ-8 throwback swagger, and given it the full-on SRT treatment. It's a mad machine, barreling into the future with one foot firmly planted in its legendary past. You ask any...
Continue Reading
From Local Fixture to National Recognition Ravi Bhalla, owner of PostalAnnex #16006 in Calabasas, CA, takes home the Crystal Award at Annex Brands' 2026 National Convention in Vegas. And let me tell you, this isn't just some shiny trophy to stuff in a display case. This is major. Shattering Sales Goals What's the big kerfuffle over? It's this: Bhalla cracked the $5...
Continue Reading
Top 5 Most Recently Viewed Articles
The Expansion of the Dry Age-Related Macular Degeneration Market The Dry Age-related Macular Degeneration (AMD) market is experiencing significant growth, with projections indicating an increase from USD 4.83 billion in recent years to an impressive USD 10.57 billion by the year 2032. This remarkable growth, anticipated at a compound annual growth rate (CAGR) of 9.1% from...
Continue Reading
Eli Lilly's Earnings Outlook: A Critical Moment Eli Lilly & Co. (NYSE: LLY) is gearing up for its upcoming earnings report, an event that many investors will monitor closely. The pharmaceutical giant has recently solidified its dominance in the weight-loss drug sector with its newest offering, Zepbound, which currently holds an impressive 59% share of U.S. prescriptions....
Continue Reading
Dream Finders Homes' Third Quarter Performance Overview Dream Finders Homes, Inc. (NYSE: DFH) released its financial outcomes for the third quarter. The homebuilder showcased remarkable growth, with revenues reaching $986 million, up 10% compared to $894 million in the same quarter last year. Key Highlights from the Third Quarter 2024 Notable achievements include a 5%...
Continue Reading
CrowdStrike's Recognition in the IDC MarketScape 2024 CrowdStrike (NASDAQ: CRWD) has achieved significant recognition for its contributions in the realm of cybersecurity, being named a Major Player in the IDC MarketScape's 2024 Worldwide Security Information and Event Management (SIEM) for Enterprise Vendor Assessment report. This assessment acknowledges CrowdStrike's...
Continue Reading
Revolutionary Therapeutic Chair for Enhanced Comfort A new therapeutic chair has been developed to provide relief for those suffering from lower back pressure and pain. An inventor from Grayson identified the need for a chair that not only supports proper posture but also offers lumbar support, enhancing overall sitting experience. Features of the EVENT COMFORT CHAIR This...
Continue Reading